Combination therapies employing multifunctional NPs provide a particularly compelling approach in PD by simultaneously targeting oxidative stress and neuroinflammation, which are key drivers of disease pathology [296,297,298]
Human Trials That Could Advance Practice in the Near-Term Beyond the trials in progress listed at the bottom of this article, there are a number of study questions which we believe could rapidly advance our knowledge for important use cases in the near to mid-term and bring GLP-1s into the clinic faster
Such capsules exist,2 but we were unable to find definitive proof (e.g., a clinical trial mentioning it) that Pendulum uses them
References Elmaleh-Sachs A, Schwartz JL, Bramante CT, Nicklas JM, Gudzune KA, Jay M
N.et al